Researcher
Erwin Dreesen
- Disciplines:Biomarker evaluation, Biopharmaceutics, Pharmacodynamics, Pharmacokinetics, Pharmacotherapy, Computational biomodelling and machine learning
Affiliations
- Department of Pharmaceutical and Pharmacological Sciences (Department)
Member
From1 Oct 2021 → 30 Sep 2022 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2019 → Today - Therapeutic and Diagnostic Antibodies (Division)
Member
From1 Sep 2014 → 30 Sep 2019
Projects
1 - 10 of 15
- Handling of social determinants in pharmacokinetics-pharmacodynamics analyses to enhance equity and inclusion in drug dosing in neonates, children, and adolescentsFrom4 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Model informed Dosage optimization of Crizanlizumab for the management of Sickle Cell Disease in TanzaniaFrom17 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Joint pharmacometrics modeling of antimicrobial exposure, biomarkers, and clinical outcome assessments to improve the in silico exploration of dose optimization strategies in critically ill patientsFrom28 Aug 2023 → TodayFunding: FWO Strategic Basic Research Grant
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Model-informed precision dosing of tacrolimus in solid organ transplant recipientsFrom27 Jul 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Pharmacodynamics models to bridge the gap between exposure and response to antimicrobial treatmentsFrom1 Oct 2021 → 30 Sep 2023Funding: BOF - projects
- Antibacterial dose optimisation based on augmented renal clearance in adult critically ill patients and selected pediatric patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- Master protocol methodological pharmacometrics researchFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Gastrointestinal physiology and drug disposition in geriatric patientsFrom5 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Beyond optimising drug exposure: Pharmacodynamic models to bridge the gap between exposure and response to antimicrobial treatmentsFrom15 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 97
- Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe(2024)
Authors: Erwin Dreesen
- Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and pain.(2024)
Authors: Livia Guadagnoli, Erwin Dreesen
Pages: e14787 - Agreement Between a Colorimetric Assay and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Quantifying Paracetamol Plasma Concentrations(2024)
Authors: Erwin Dreesen, Karel Allegaert, Lorenz Van der Linden, Jos Tournoy
- Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle(2024)
Authors: Zhigang Wang, Erwin Dreesen
Pages: 316 - 317 - Identifying risk factors of anti-TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel disease(2024)
Authors: Karen van Hoeve, Debby Thomas, Ilse Hoffman, Erwin Dreesen
Pages: 95 - 104 - TRPA1 Antagonist LY3526318 Inhibits the Cinnamaldehyde-Evoked Dermal Blood Flow Increase: Translational Proof of Pharmacology(2023)
Authors: Dorien Bamps, Erwin Dreesen, Heleen Marynissen
Pages: 1093 - 1103 - Therapeutic Drug Monitoring Can Guide the Intravenous-to-Subcutaneous Switch of Infliximab and Vedolizumab: A Simulation Study(2023)
Authors: Zhigang Wang, Bram Verstockt, João Guedelha Sabino, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
Pages: 3188 - 3190 - Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review(2023)
Authors: Beatrijs Mertens, Omar Elkayal, Erwin Dreesen, Joost Wauters, Yves Debaveye, Pieter Vermeersch, Matthias Gijsen
- Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates(2023)
Authors: Yani Berckmans, Yannick Hoffert, Erwin Dreesen, An Coosemans
- A Model-Based Tool for Guiding Infliximab Induction Dosing to Maximize Long-term Deep Remission in Children with Inflammatory Bowel Diseases(2023)
Authors: Wannee Kantasiripitak, Debby Thomas, Ilse Hoffman, Marc Ferrante, Séverine Vermeire, Karen van Hoeve, Erwin Dreesen
Pages: 896 - 908